0001453687-23-000087.txt : 20231115
0001453687-23-000087.hdr.sgml : 20231115
20231115172010
ACCESSION NUMBER: 0001453687-23-000087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231113
FILED AS OF DATE: 20231115
DATE AS OF CHANGE: 20231115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPRINGER TIMOTHY A
CENTRAL INDEX KEY: 0001055624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 231411615
MAIL ADDRESS:
STREET 1: 36 WOODMAN ROAD
CITY: CHESTNUT HILL
STATE: MA
ZIP: 02467
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cartesian Therapeutics, Inc.
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: SELECTA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090109
4
1
wk-form4_1700086801.xml
FORM 4
X0508
4
2023-11-13
0
0001453687
Cartesian Therapeutics, Inc.
RNAC
0001055624
SPRINGER TIMOTHY A
36 WOODMAN ROAD
CHESTNUT HILL
MA
02467
1
0
1
0
0
Series A Convertible Preferred Stock
2023-11-15
4
A
0
24785.081
403.4685
A
24785.081
I
See Footnote
Series A Convertible Preferred Stock
2023-11-15
4
A
0
123925.407
403.4685
A
123925.407
D
Common Stock
86418
I
By wife
Common Stock
7293625
D
Common Stock
29868490
I
See Footnote
Stock Option (Right to Buy)
17.47
2023-11-13
4
D
0
6410
D
2027-06-15
Common Stock
6410
0
D
Stock Option (Right to Buy)
12.75
2023-11-13
4
D
0
10000
D
2028-06-14
Common Stock
10000
0
D
Stock Option (Right to Buy)
2.10
2023-11-13
4
D
0
10000
D
2029-06-13
Common Stock
10000
0
D
Stock Option (Right to Buy)
3
2023-11-13
4
D
0
20000
D
2030-06-18
Common Stock
20000
0
D
Stock Option (Right to Buy)
4.01
2023-11-13
4
D
0
40000
D
2031-03-29
Common Stock
40000
0
D
Stock Option (Right to Buy)
3.31
2023-11-13
4
D
0
40000
D
2032-01-02
Common Stock
40000
0
D
Stock Option (Right to Buy)
1.13
2023-11-13
4
D
0
75000
0.93
D
2033-01-01
Common Stock
75000
0
D
Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
This option, which provided for vesting in full on June 14, 2018, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc.
This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger.
This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger.
This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger.
This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger.
This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger.
This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $69,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
2023-11-15